EVOLUATION OF sCD14 BIOMARKER IN INTRAABDOMINAL HYPERTENSION IN PATIENTS WITH ACUTE SURGICAL DISEASES


  • E. М. Turgunov Karaganda State Medical University, Kazakhstan
  • M.M. Mugazov Karaganda State Medical University, Kazakhstan
Keywords: intra-abdominal hypertension, abdominal compartment syndrome, sCD14 biomarker

Abstract

EVOLUATION OF sCD14 BIOMARKER IN INTRAABDOMINAL HYPERTENSION IN PATIENTS WITH ACUTE SURGICAL DISEASES

References

1. Mugazov M.M. Clinical and laboratory indicators for emergency abdominal pathology, depending on the degree of intra-abdominal hypertension / M.M. Mugazov, E.M. Turgunov, N.O. Musin // thesis. - 2016. - С. - 9.

2. Velkov V.V. Presepsin is a new high-performance sepsis biomarker. Clinical and laboratory consultation, Scientific and Practical Journal 2012, No. 2, 56-62.

3. Yaegashi Y, Shirakawa K, Sato N et al. Evaluation of a newly identified soluble CD14 subtype as a marker for sepsis. J Infect Chemother. 2005;11(5):234-8.

4. Endo S, Takahashi G, Shozushima T et al. Usefulness of Presepsin (Soluble CD14 Subtype) as a Diagnostic Marker for Sepsis. JJAAM. 2012;23:27-38

5. Agilli M., Sener I., Yesildal F. et al, A new marker for the diagnosis of sepsis: Presepsin. J Investig Biochem. 2012;1(1):55-57

6. Faix JD, Presepsin — The new kid on the sepsis block, Clin. Biochem.2014; 47(7-8):503-4).

7. Pizzolato E, Ulla M, Galluzzo C et al. Role of presepsin for the evaluation of sepsis in the emergency department. Clin Chem Lab Med. 2014 Jun 4 [Epub ahead of print].

8. Zou Q, Wen W, Zhang X. Presepsin as a novel sepsis biomarker. World J Emerg Med, 2014, 5, 16-19.

9. Okamura I, Tome R. Pressepsin: a new biomarker for predicting and diagnosing sepsis. “Laboratory”, 2014, N1, c. 9-10.
Published
2018-11-15
How to Cite
TurgunovE. М., & Mugazov, M. (2018). EVOLUATION OF sCD14 BIOMARKER IN INTRAABDOMINAL HYPERTENSION IN PATIENTS WITH ACUTE SURGICAL DISEASES. Biological Markers in Fundamental and Clinical Medicine (collection of Abstracts), 2(2), 43-44. https://doi.org/10.29256/v.02.02.2018.escbm34
Section
Selected abstracts